Select Medical (NYSE:SEM) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Wednesday.
According to Zacks, “Select Medical Holdings Corporation, through its subsidiaries, operates specialty hospitals and outpatient rehabilitation clinics. The company’s Specialty Hospital segment offers long-term acute care hospital services and inpatient acute rehabilitative hospital care services. Its Outpatient Rehabilitation segment operates clinics and provides physical, occupational, and speech rehabilitation services. The company also provides medical rehabilitation services on a contract basis to nursing homes, hospitals, assisted living and senior care centers, schools, and work sites. The Mission of Select Medical Corporation is to ensure high-quality health care and cost-effective outcomes by providing specialty inpatient long-term acute care and rehabilitation, and outpatient rehabilitation services. The company is headquartered in Mechanicsburg, Pennsylvania. “
Several other analysts have also recently commented on SEM. ValuEngine upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Royal Bank of Canada restated a “buy” rating and set a $19.00 price objective on shares of Select Medical in a research note on Wednesday, September 13th. Robert W. Baird set a $25.00 price objective on shares of Select Medical and gave the company a “buy” rating in a research note on Monday, October 23rd. Finally, Deutsche Bank restated a “buy” rating and set a $22.00 price objective on shares of Select Medical in a research note on Monday, November 6th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $19.50.
Select Medical (NYSE:SEM) last released its earnings results on Thursday, November 2nd. The health services provider reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.02). The company had revenue of $1.10 billion for the quarter, compared to analysts’ expectations of $1.10 billion. Select Medical had a return on equity of 11.44% and a net margin of 2.21%. The firm’s revenue for the quarter was up 4.1% on a year-over-year basis. During the same period in the prior year, the firm posted $0.06 EPS. research analysts anticipate that Select Medical will post 0.85 earnings per share for the current fiscal year.
In related news, insider Scott A. Romberger sold 5,000 shares of the business’s stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $17.97, for a total value of $89,850.00. Following the completion of the transaction, the insider now directly owns 168,211 shares in the company, valued at approximately $3,022,751.67. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider David S. Chernow sold 133,025 shares of the business’s stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $17.85, for a total transaction of $2,374,496.25. Following the completion of the transaction, the insider now owns 729,815 shares of the company’s stock, valued at $13,027,197.75. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 156,525 shares of company stock valued at $2,815,291. Company insiders own 19.93% of the company’s stock.
Several institutional investors and hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. lifted its stake in shares of Select Medical by 3.9% in the 2nd quarter. Vanguard Group Inc. now owns 9,929,821 shares of the health services provider’s stock valued at $152,423,000 after purchasing an additional 369,044 shares during the period. Dimensional Fund Advisors LP lifted its stake in shares of Select Medical by 1.8% in the 3rd quarter. Dimensional Fund Advisors LP now owns 8,289,370 shares of the health services provider’s stock valued at $159,154,000 after purchasing an additional 146,892 shares during the period. Orbimed Advisors LLC lifted its stake in shares of Select Medical by 51.3% in the 3rd quarter. Orbimed Advisors LLC now owns 5,578,500 shares of the health services provider’s stock valued at $107,107,000 after purchasing an additional 1,891,100 shares during the period. Northern Trust Corp lifted its stake in shares of Select Medical by 14.6% in the 2nd quarter. Northern Trust Corp now owns 2,325,289 shares of the health services provider’s stock valued at $35,694,000 after purchasing an additional 296,087 shares during the period. Finally, Voya Investment Management LLC lifted its stake in shares of Select Medical by 24.5% in the 2nd quarter. Voya Investment Management LLC now owns 1,850,668 shares of the health services provider’s stock valued at $28,407,000 after purchasing an additional 364,721 shares during the period. Hedge funds and other institutional investors own 77.93% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This story was first posted by American Banking News and is the property of of American Banking News. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright law. The legal version of this story can be accessed at https://www.americanbankingnews.com/2017/12/13/select-medical-sem-downgraded-by-zacks-investment-research-to-sell.html.
About Select Medical
Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.